Description: Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Home Page: www.immunovia.com
Medicon Village
Lund,
223 63
Sweden
Phone:
46 4 62 75 60 00
Officers
| Name | Title |
|---|---|
| Mr. Jeff Borcherding | Global Chief Executive Officer & President |
| Ms. Karin Almqvist Liwendahl | Chief Financial Officer |
| Ms. Lara E. Sucheston-Campbell | Head of Clinical & Medical Affairs |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.1992 |
| Price-to-Book MRQ: | 2.5166 |
| Price-to-Sales TTM: | 13.3991 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 10 |